Article
microRNA-34a sensitizes lung cancer cell lines to DDP treatment independent of p53 status.
Cancer biotherapy & radiopharmaceuticals - 1 Feb 2013
Wang Xi, Dong Ke, Gao Ping, Long Min, Lin Fang, Weng Yuanyuan, Ouyang Yongri, Ren Jihong, Zhang Huizhong
Abstract excerpt
miR-34a was identified as one of the downregulated microRNAs (miRNAs) in human lung cancer. However, the precise biological role of miR-34a in p53 deficient lung cancer cell lines remains largely elusive. In the present study, we aimed to identify the role of miR-34a in the regulation of lung cancer cell proliferation. Using quantitative RT-PCR analysis, we found that miR-34a was highly upregulated in the p53...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
